No Data
Haofan Biotechnology (301393.SZ) has established a wholly-owned subsidiary in Germany.
Haofan Biotech (301393.SZ) announced that, according to the company's development and Global Strategy requirements, the company has established a wholly-owned subsidiary in Germany...
Haofan Bio (301393.SZ): A total of 0.95% of shares repurchased, the buyback has been completed.
On February 5, Gelonghui announced that Haofan Bio (301393.SZ) has, as of the date of this announcement, cumulatively repurchased 1,028,148 shares of the company through a dedicated Share Buyback account via centralized bidding Trade, accounting for 0.95% of the company's current total share capital. The highest Fill Price was 51.50 yuan/share, the lowest Fill Price was 33.46 yuan/share, and the total amount for the Trades was 41,995,798.68 yuan (excluding transaction fees). The total amount of funds used for the repurchased shares has reached the lower limit of the repurchase plan, and has not exceeded the upper limit of the funds for repurchased shares, this Share Buyback.
Overview of the lifting of restrictions on A-shares by Zhitong | January 13.
According to Zhito Finance APP, on January 13, a total of 14 listed companies had their restricted stocks released, with a total market value of approximately 9.316 billion yuan. The specific status of the restricted stock release today is as follows: Stock Abbreviation Stock Code Type of Restricted Stock Number of Released Stocks Tai Mushi 001234 Pre-issue Shares Restricted Circulation 77.6 million Shanghai Bairun Investment Holding Group 002568 Stock-based Incentive Restricted Circulation 1.0696 million Ningbo Sanxing Medical Electric 601567 Stock-based Incentive Restricted Circulation 3.8059 million Ningbo Peacebird Fashion 603877 Stock-based Incentive Restricted Circulation 1.149 million Zhejiang Tiantai Xianghe Industrial 603500 Stock-based Incentive Restricted Circulation 1.138 million Haofan Biology 3
Haofan Bio (301393.SZ) will have 13.136 million restricted shares listed and become tradable on January 15.
Haofan Biological (301393.SZ) announced that the number of Shareholders whose restrictions on sales are lifted this time is 5, with a total number of shares being 1...
Suzhou Highfine Biotech Co., Ltd.'s (SZSE:301393) Largest Shareholder, CEO Yong Zhu Sees Holdings Value Fall by 7.4% Following Recent Drop
Additional Considerations Required While Assessing Suzhou Highfine Biotech's (SZSE:301393) Strong Earnings
Should Weakness in Suzhou Highfine Biotech Co., Ltd.'s (SZSE:301393) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
